Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Oct;46(10):1921-1923.
doi: 10.1007/s00134-020-06171-7. Epub 2020 Jul 8.

Serum antibody response in critically ill patients with COVID-19

Alban Longchamp #  1   2   3 , Justine Longchamp #  1   3 , Antony Croxatto  4 , Gilbert Greub  4 , Bienvenido Sanchez #  5 , Julie Delaloye #  6 ; Study Group
Collaborators, Affiliations
Comment

Serum antibody response in critically ill patients with COVID-19

Alban Longchamp et al. Intensive Care Med. 2020 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

All authors declare no conflicts of interest.

Figures

Fig. 1
Fig. 1
Serological profile of critically ill patients with Covid-19. a anti-N IgG levels in patients over time since the admission to the ICU. b, c Interval from ICU admission (b), and symptom onset (c) in samples considered positive for SARS-CoV-2-specific IgG antibodies. d Unparametric Spearman’s correlation between anti-N IgG levels at ICU admission, and corresponding time from symptom onset with their coefficient of determination R2 and p value. Dashed lines indicate 95% confidence intervals. (e) Pooled sera antibody levels in survivor versus non-survivors. f, g Individual patient SARS-Cov-2 E gene threshold cycle (CT) values since admission to the ICU (f), and grouped with anti-N IgG profile (g). Data are expressed as mean ± SD. For negative qPCR, CT values were arbitrary set at 40
See this image and copyright information in PMC

Comment on

  • The important role of serology for COVID-19 control.
    Winter AK, Hegde ST. Winter AK, et al. Lancet Infect Dis. 2020 Jul;20(7):758-759. doi: 10.1016/S1473-3099(20)30322-4. Epub 2020 Apr 21. Lancet Infect Dis. 2020. PMID: 32330441 Free PMC article. No abstract available.

References

    1. Yang X, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–481. doi: 10.1016/S2213-2600(20)30079-5. - DOI - PMC - PubMed
    1. Richardson S, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052–2059. doi: 10.1001/jama.2020.6775. - DOI - PMC - PubMed
    1. Winter AK, Hegde ST. The important role of serology for COVID-19 control. Lancet Infect Dis. 2020;20(7):758–759. doi: 10.1016/S1473-3099(20)30322-4. - DOI - PMC - PubMed
    1. To KK, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;20(5):565–574. doi: 10.1016/S1473-3099(20)30196-1. - DOI - PMC - PubMed
    1. Zhao J, Yuan Q, Wang H, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis. 2020 doi: 10.1093/cid/ciaa344. - DOI - PMC - PubMed

LinkOut - more resources